An official website of the United States government
Publication Information
Affiliation
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. unruh@pitt.edu
Authors
Beddhu S, Benz R, DeVita M, Dwyer JT, Greene T, HEMO Study Group, Kimmel PL, Kusek JW, Martin A, Meyer KB, Rehm-McGillicuddy J, Teehan BP, Unruh M, Yan G
Studies
Citation
Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB, HEMO Study Group. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int 2004 Jul;66(1):355-66.Abstract
It has been widely supposed that high dose and high flux hemodialysis would affect the quality as well as the length of life of patients treated by maintenance hemodialysis. The HEMO Study examined changes in health-related quality of life as a secondary study outcome. Specific hypotheses were that study interventions would affect physical functioning, vitality, Short Form-36 Health Survey (SF-36) physical and mental component summary scores, symptoms and problems associated with kidney disease, and sleep quality.